CDC authorise Pfizer boosters for 16- and 17-year-olds
December 10, 2021Medical Communications
The FDA and CDC have authorised booster vaccinations of the Pfizer-BioNTech COVID-19 vaccine for teenagers aged 16 and 17. The …
FDA approves expansion for ZYNRELEF
December 10, 2021Medical Communications
The FDA has approved Heron Therapeutics’ supplemental New Drug Application (sNDA) for ZYNRELEF (bupivacaine and meloxicam), to significantly expand the …
Novartis announces positive results from Phase III trial of Beovu
December 9, 2021Business Services
Novartis have announced the first interpretable results from year two (week 100) of the Phase III KESTREL study. KESTREL assessed …
Pfizer says COVID-19 booster shot is promising against Omicron variant
December 9, 2021The companies said that the three doses provide a similar level of antibodies against Omicron, compared to that of two …
FDA approval for first CGP test for melanoma therapeutics
December 9, 2021Business Services
The FDA has granted Foundation Medicine approval for its companion diagnostic, FoundationOne®CDx, for two groups of current and future FDA-approved …
EUA granted to AstraZeneca’s antibody therapy for COVID-19 prevention
December 9, 2021Business Services
AstraZeneca announced that its Evusheld antibody combination for the prevention of COVID-19 in immunocompromised adults and adolescents has been granted …
Abbott receives CE mark for traumatic brain injury blood test
December 8, 2021Research and Development
Abbott has received a CE mark for its laboratory traumatic brain injury (TBI) blood test. This will be the first …
Positive Phase III trial results for plant-based COVID-19 vaccine candidate
December 8, 2021Research and Development
The biopharmaceutical company Medicago, alongside GlaxoSmithKline, have announced positive efficacy and safety results from the global Phase III placebo-controlled efficacy …
Booster vaccines may be needed for ‘years to come’, says Pfizer
December 8, 2021Research and Development
Ben Osborn, country manager for Pfizer in the UK, has shared that coronavirus booster jabs will likely be necessary “for …
WHO reject convalescent plasma treatment for COVID-19
December 7, 2021Manufacturing and Production
WHO now strongly recommend against the use of convalescent plasma in the treatment of COVID-19 patients regardless of their stage …
Study reveals young people recover quickly from rare COVID-19 side effect
December 7, 2021Manufacturing and Production
Most young people under the age of 21 who develop suspected COVID-19 myocarditis (inflammation of the muscle), show mild symptoms …
GSK antibody treatment effective against Omicron, study suggests
December 7, 2021Manufacturing and Production
GlaxoSmithKline Plc have shared that research shows its antibody treatment is effective against the range of mutations in the recently-emerged …
Acadia Pharmaceuticals achieve positive Phase III results in Rett Syndrome trial
December 7, 2021Manufacturing and Production
Acadia Pharmaceuticals have announced positive top-line results from the pivotal, Phase III Lavender study, which evaluated the efficacy and safety …
Maintaining product authenticity: The solution to a serial problem
December 6, 2021Sales and Marketing
Counterfeit medicines pose a serious risk to public safety, and, in some cases, can lead to serious adverse effects (SAE) …
Sidelined or streamlined? Diabetic care and COVID-19
December 6, 2021Sales and Marketing
The worldwide restrictions put in place as a result of COVID-19 have necessitated innovation in multiple medical spheres. Diabetes, which …
TIB Molbiol develops test kits for Omicron variant detection
December 6, 2021Sales and Marketing
TIB Molbiol, a newly acquired subsidiary of Roche, has developed three new VirSNiP test kits for the detection of mutations …
FDA grants Lilly’s COVID-19 antibody therapy EUA for paediatric use
December 6, 2021Sales and Marketing
Eli Lilly has been granted an expanded Emergency Use Authorisation (EUA) for its neutralising antibody treatment, based on the safety …
J&J COVID-19 booster shows increase in antibody and T-cell responses, in Phase II trial
December 6, 2021Sales and Marketing
Johnson & Johnson have announced positive results from an independent Phase II study, which reveal that a booster shot of …
Omicron could become dominant variant in UK within weeks, expert warns
December 6, 2021Research and Development
Infectious diseases expert, Professor Paul Hunter, has warned that Omicron could become the UK’s dominant COVID-19 variant within weeks.The UK …
UK study shows Pfizer and Moderna jabs give best COVID-19 protection
December 3, 2021Medical Communications
The Pfizer and Moderna booster vaccines have been shown to provide the best overall boost response, according to a UK …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
